跳至主要内容
临床试验/NCT02722993
NCT02722993已完成不适用

Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders

Probi AB1 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2016年2月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Probi AB
入组人数
117
试验地点
1
主要终点
Number of loose/watery stools

研究概览

简要总结

To assess the effect of a probiotic product, when co-administered with antibiotics, on gastrointestinal symptoms following antibiotic treatment in children.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children at the age of 1-11 years that have been prescribed antibiotic treatment.
  • Problems with loose stools during earlier antibiotic treatments.
  • Children whose parents or legal caregivers have signed the informed consent to participate in the study.

排除标准

  • Chronic intestinal disease, immunodeficiency or immunosuppressive treatment.
  • Chronic or acute diarrheal disease.
  • Use of laxatives the week before inclusion in the study.
  • Antibiotic treatment for the last four weeks before inclusion in the study.
  • Intake of probiotic products for the last two weeks before inclusion in the study.
  • Known hypersensitivity to any of the ingredients in the probiotic product or the placebo (potato starch ± bacterial culture that may contain traces of soy).
  • Patient requiring hospitalisation.

研究组 & 干预措施

Probiotics

Active Comparator

干预措施: Probiotics (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Number of loose/watery stools

时间窗: 19-26 days

次要结局

未报告次要终点

研究者

发起方
Probi AB
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验